Amgenâ??S Vectibix Misses Overall Survival Endpoint In Colorectal Cancer

Amgenâ??s Vectibix failed to improve overall survival in a Phase III clinical trial evaluating it as a first-line treatment in metastatic colorectal cancer, according to the company....

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

Russia says bomb caused deadly train crash (Reuters) - Yahoo! News

Scientology plans Illinois headquarters in Printer's Row - Chicago Tribune

Abu Dhabi to Help Case by Case - CNBC

City targets ex-NBA star for 'slum' housing: Walker 'humbly apologizes' for 'failings - Individual.com

Terrorism suspected in Russian train crash - Telegraph

Featured Members

Matthew Clark
Mentor
Entrepreneur

Leo Petrik
Founder & CEO
Entrepreneur

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map